2.85
price up icon8.37%   0.22
after-market アフターアワーズ: 2.91 0.06 +2.11%
loading
前日終値:
$2.63
開ける:
$2.7
24時間の取引高:
1.10M
Relative Volume:
0.69
時価総額:
$203.23M
収益:
-
当期純損益:
$-192.96M
株価収益率:
-0.8636
EPS:
-3.3
ネットキャッシュフロー:
$-167.04M
1週間 パフォーマンス:
+12.65%
1か月 パフォーマンス:
+4.01%
6か月 パフォーマンス:
+69.64%
1年 パフォーマンス:
+46.15%
1日の値動き範囲:
Value
$2.66
$2.94
1週間の範囲:
Value
$2.36
$2.94
52週間の値動き範囲:
Value
$0.783
$3.39

Ventyx Biosciences Inc Stock (VTYX) Company Profile

Name
名前
Ventyx Biosciences Inc
Name
セクター
Healthcare (1161)
Name
電話
(858) 945-2393
Name
住所
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Name
職員
79
Name
Twitter
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
VTYX's Discussions on Twitter

VTYX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VTYX
Ventyx Biosciences Inc
2.85 187.54M 0 -192.96M -167.04M -3.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.92 99.42B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.55 58.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.52 56.35B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
646.60 39.02B 3.06B 1.28B -614.78M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.51 34.25B 3.81B -644.79M -669.77M -6.24

Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-03-12 アップグレード Oppenheimer Perform → Outperform
2024-03-12 アップグレード Wells Fargo Equal Weight → Overweight
2023-11-07 ダウングレード H.C. Wainwright Buy → Neutral
2023-11-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-11-07 ダウングレード Oppenheimer Outperform → Perform
2023-11-07 ダウングレード Stifel Buy → Hold
2023-11-07 ダウングレード Wells Fargo Overweight → Equal Weight
2023-06-14 再開されました Credit Suisse Outperform
2023-03-21 開始されました Wells Fargo Overweight
2022-12-19 開始されました Goldman Buy
2022-11-17 開始されました Morgan Stanley Overweight
2022-09-07 開始されました Stifel Buy
2022-09-01 開始されました H.C. Wainwright Buy
2022-05-09 開始されました Credit Suisse Outperform
2022-03-31 開始されました Canaccord Genuity Buy
2022-02-01 開始されました Oppenheimer Outperform
2021-11-15 開始されました Jefferies Buy
2021-11-15 開始されました Piper Sandler Overweight
すべてを表示

Ventyx Biosciences Inc (VTYX) 最新ニュース

pulisher
Aug 13, 2025

Ventyx Biosciences Inc. Stock Approaches Key Moving AverageWeekly Market Summary & Entry Point Confirmation Alerts - beatles.ru

Aug 13, 2025
pulisher
Aug 13, 2025

How institutional ownership impacts Ventyx Biosciences Inc. stockJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Will Ventyx Biosciences Inc. stock go up soon2025 Top Decliners & Technical Buy Zone Confirmations - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What MACD and RSI say about Ventyx Biosciences Inc.Recession Risk & Daily Growth Stock Investment Tips - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Tools to monitor Ventyx Biosciences Inc. recovery probabilityWeekly Volume Report & Daily Price Action Insights - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Ventyx Biosciences Inc. stock prediction for this weekWeekly Trend Summary & Fast Moving Trade Plans - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Published on: 2025-08-12 23:04:56 - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Has Ventyx Biosciences Inc. Stock Ever Crashed Historical Volatility ReviewValue Holding Return Summary With Outlook - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

What technical models suggest about Ventyx Biosciences Inc.’s comebackTrend Reversal & AI Forecast Swing Trade Picks - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Can Ventyx Biosciences Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Aug 11, 2025
pulisher
Aug 11, 2025

Smart tools for monitoring Ventyx Biosciences Inc.’s price actionReversal Signal Prediction Based on Volume - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Detecting support and resistance levels for Ventyx Biosciences Inc.Weekly Outlook for Short Term Investors - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

What MACD signals say about Ventyx Biosciences Inc.Free Weekly Watchlist of High Movers - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Building trade automation scripts for Ventyx Biosciences Inc.Free Weekly Stock Opportunity Radar Scanner - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

What recovery options are there for Ventyx Biosciences Inc.Free Real Trader Watchlist of Hot Stocks - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Ventyx Biosciences Inc. stock chart pattern explainedSwing Trade Watchlist with Entry Zones - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

A Quick Look at Today's Ratings for Ventyx Biosciences(VTYX.US), With a Forecast Between $9 to $21 - 富途牛牛

Aug 09, 2025
pulisher
Aug 09, 2025

Ventyx Biosciences Earns Buy Rating: Analyst Cites Promising Developments - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Real time social sentiment graph for Ventyx Biosciences Inc.Chart Pattern Recognition for Profit Timing - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

H.C. Wainwright Keeps Their Hold Rating on Ventyx Biosciences (VTYX) - The Globe and Mail

Aug 09, 2025
pulisher
Aug 09, 2025

Wall Street Zen Upgrades Ventyx Biosciences (NASDAQ:VTYX) to “Hold” - Defense World

Aug 09, 2025
pulisher
Aug 08, 2025

Why Ventyx Biosciences Inc. stock attracts strong analyst attentionFree Oversold Recovery Opportunity Stocks - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Is Ventyx Biosciences Inc. forming a bottoming baseChart Scanner for Swing Trade Timing - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Applying big data sentiment scoring on Ventyx Biosciences Inc.Entry Zone Watchlist With Momentum Focus - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Ventyx Biosciences shares surge 12.50% intraday after reporting better-than-expected Q2 earnings and positive biomarker data for VTX3232 in Parkinson's treatment. - AInvest

Aug 08, 2025
pulisher
Aug 07, 2025

Ventyx Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Ventyx Biosciences Q2 2025 Earnings Beat Estimates, Cash Position at $209M - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Ventyx (VTYX) Q2 Net Loss Drops 16% - The Globe and Mail

Aug 07, 2025
pulisher
Aug 07, 2025

Ventyx Biosciences Q2 GAAP EPS of -$0.38 Beats Expectations - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Ventyx Biosciences Q2 FY25 Revenue $5.4mln, Cash Balance $209mln. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Ventyx Breakthrough: Phase 2 Parkinson's Drug Shows Promise, Plus Two Major Trial Results Expected in Q4 2025 - Stock Titan

Aug 07, 2025
pulisher
Aug 07, 2025

What candlestick patterns are forming on Ventyx Biosciences Inc.Free Accurate Buy Point for Momentum Stocks - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Ventyx Biosciences (VTYX) Projected to Post Earnings on Thursday - Defense World

Aug 07, 2025
pulisher
Aug 04, 2025

Options Data Show Bullish Bias in Ventyx Biosciences Inc.Watchlist for Low Risk High Return Stocks Updated - beatles.ru

Aug 04, 2025
pulisher
Aug 04, 2025

Will Ventyx Biosciences Inc. Bounce From 52 Week LowChart Driven High Reward Trading Setup Presented - beatles.ru

Aug 04, 2025

Ventyx Biosciences Inc (VTYX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.46
price up icon 1.67%
$85.85
price up icon 5.20%
$26.87
price up icon 4.61%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
大文字化:     |  ボリューム (24 時間):